B-cell receptor specific for influenza H5N1 antigens (H5N1-specific BCR)

B-cell receptors (BCRs) specific for influenza H5N1 antigens are membrane-bound immunoglobulins on the surface of B lymphocytes that recognize and bind to the hemagglutinin (HA) or neuraminidase (NA) proteins of the H5N1 avian influenza virus. These receptors are essential for the adaptive immune response, as their activation leads to the production of neutralizing antibodies that can prevent viral infection and spread (Wrammert et al., 2008). In the context of H5N1, BCRs often utilize specific germline genes, such as VH1-69, to target conserved regions like the HA stem, making them a primary focus for universal vaccine design (Lingwood et al., 2012). Vaccines like Audenz work by presenting H5N1 antigens to these BCRs to stimulate a protective immune memory (CDC, 2024). Furthermore, monoclonal antibodies such as CR6261 have been developed by cloning the variable regions of these specific BCRs to provide passive immunity against H5N1 (Throsby et al., 2008). However, the high mutation rate of the H5N1 virus and the phenomenon of original antigenic sin pose significant challenges to effectively targeting these receptors (Khurana et al., 2013). Understanding the structural basis of BCR-antigen interactions is crucial for developing next-generation immunotherapies and vaccines that provide broad protection against emerging pandemic threats.

Other names

H5N1-specific B-cell receptorH5N1-reactive BCRAnti-H5N1 surface immunoglobulinH5N1-specific sIg

Antigen-induced receptor clustering and signaling through the Ig-alpha/Ig-beta (CD79A/CD79B) heterodimer, leading to B-cell differentiation and production of H5N1-specific antibodies.